skye tirzepatide Bioscience, Inc. (SKYE) Securities Class Action Lawsuit Update [December 10, 2025] Your Complete Guide to Semaglutide

The Bottom Line GLP-1 agonists are powerful and effective medications for Type 2 diabetes and obesity

It is a Schedule IV controlled substance class of drug in terms of how it will be regulated, similar to other injectable weight-loss medications

NAION involves blood loss to the optic nerve that can lead to visual impairments and blindness

It may also worsen side effects such as dizziness, nausea, and dehydration

This frames the conversation as a collaborative discussion about your care rather than a demand for a particular product

Beyond Stem Cells works with financing partners who approve plans allowing you to spread costs over 6-24 months with monthly payments